The intravenous administration of a formulation of interleukin-12 that binds to collagen in established ‘immunologically cold’ murine tumours enhances interferon-γ production by T cells and causes tumour remission, especially when in combination with immune checkpoint blockade therapy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Topalian, S. L., Drake, C. G. & Pardoll, D. M. Cancer Cell 27, 450–461 (2015).
Wherry, E. Nat. Immunol. 12, 492–499 (2011).
Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. Nature 362, 758–761 (1993).
Galon, J. & Bruni, D. Immunity 52, 55–81 (2020).
Bonaventura, P. et al. Front. Immunol. 10, 168 (2019).
Lasek, W., Zagozdzon, R. & Jakobisiak, M. Cancer Immunol. Immunother. 63, 419–435 (2014).
Kobayashi, M. et al. J. Exp. Med. 170, 827–845 (1989).
Stern, A. S. et al. Proc. Natl Acad. Sci. USA 87, 6808–6812 (1990).
Otani, T. et al. Cell. Immunol. 198, 111–119 (1999).
Leonard, J. et al. Blood 90, 2541–2548 (1997).
Mansurov, A. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0549-2 (2020).
Momin, N. et al. Sci. Transl. Med. 11, eaaw2614 (2019).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Scheller, J., Lang, P.A. Collagen-binding IL-12 inflames ‘cold’ tumours. Nat Biomed Eng 4, 483–484 (2020). https://doi.org/10.1038/s41551-020-0560-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-020-0560-7